Flagstaff, Ariz.-based SenesTech, a developer of technologies for managing animal pest populations through fertility control, has appointed Dr. Steve Krause as executive VP of sales and marketing at the company.
He has experience in both government agencies and the private sector with more than 25 years of experience in the agriculture and public health pest management markets worldwide. He has has a proven track record of integrating new biorational-based product solutions into operational programs. As a specialist in integrated pest management (IPM), he spearheaded a program with the World Health Organization (WHO) to launch a new class of pesticide to the global B2B and B2G vector control markets.
“Steve has a proven track record of success in developing markets, and specifically marketing and selling innovative, biorational product solutions into the pest control industry, and is eager to bring his experiences to SenesTech as we aggressively expand our sales and marketing efforts,” said Ken Siegel, SenesTech’s CEO.
Most recently, Dr. Krause was global business director at Valent BioSciences where he led their work in commercializing bio-pest solutions for the global market.
Dr. Krause has also held positions at Paramount Pest and Abbott Labs. He is a recipient of Abbott’s Summit Award for sales excellence, and his team was recognized for halting transmission of the Zika virus in Miami with a Chicago Innovation Award in 2017.
He has a bachelor of science in biology from James Madison University, a Master of Business Administration (MBA) in management from Loyola University Chicago and a Ph.D. in entomology from the University of Wisconsin.
“I am very excited to be joining SenesTech at this time,” Dr. Krause said. “ContraPest offers a new paradigm in pest control, which is not an industry that easily embraces innovation or change without good reason. By focusing on customer-centric, I am confident that the SenesTech team can provide that reason and successfully advance ContraPest.”
ContraPest is a rodent fertility control product, approved by the California Department of Pesticide Regulation (CDPR) for sale and use in California under registration #91601-1-AA.
ContraPest targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a bait delivery method, ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rat communities. According to SenesTech, ContraPest is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
SenesTech’s recently launched online store allows pest management professionals to order ContraPest directly.